Back to ACAD

Krensavage Asset Management, LLC → ACAD

Krensavage Asset Management, LLC ACAD Position History

Acadia Pharmaceuticals Inc. • Healthcare

Quarters held
1
Latest value
$806K
Q3 2026
Peak value
$806K
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$806K40.0K——

Other funds holding ACAD

Other Krensavage Asset Management, LLC positions

UTHR

UNITED THERAPEUTICS CORP

$50M
UTHR

UNITED THERAPEUTICS CORP

$44.5M
ENTA

ENANTA PHARMACEUTICALS INC

$43.6M
ENTA

ENANTA PHARMACEUTICALS INC

$41.8M
JAZZ

JAZZ PHARMACEUTICALS PLC

$40.4M
JAZZ

JAZZ PHARMACEUTICALS PLC

$38.9M
ENTA

ENANTA PHARMACEUTICALS INC

$37.8M
UTHR

UNITED THERAPEUTICS CORP

$37.5M